Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

High quality reference genomes for toxigenic and non-toxigenic Vibrio cholerae serogroup O139.

Dorman MJ, Domman D, Uddin MI, Sharmin S, Afrad MH, Begum YA, Qadri F, Thomson NR.

Sci Rep. 2019 Apr 10;9(1):5865. doi: 10.1038/s41598-019-41883-x.

2.

Correction: Phenotypic and genomic analyses of bacteriophages targeting environmental and clinical CS3-expressing enterotoxigenic Escherichia coli (ETEC) strains.

Chakraborty S, von Mentzer A, Begum YA, Manzur M, Hasan M, Ghosh AN, Hossain MA, Camilli A, Qadri F.

PLoS One. 2019 Mar 5;14(3):e0213612. doi: 10.1371/journal.pone.0213612. eCollection 2019.

3.

Field evaluation of a locally produced rapid diagnostic test for early detection of cholera in Bangladesh.

Islam MT, Khan AI, Sayeed MA, Amin J, Islam K, Alam N, Sultana N, Jahan N, Rashid MM, Khan ZH, Zion MI, Afrad MH, Siddique SA, Khanam F, Begum YA, Islam MS, Qadri F.

PLoS Negl Trop Dis. 2019 Jan 31;13(1):e0007124. doi: 10.1371/journal.pntd.0007124. eCollection 2019 Jan.

4.

Phenotypic and genomic analyses of bacteriophages targeting environmental and clinical CS3-expressing enterotoxigenic Escherichia coli (ETEC) strains.

Chakraborty S, von Mentzer A, Begum YA, Manzur M, Hasan M, Ghosh AN, Hossain MA, Camilli A, Qadri F.

PLoS One. 2018 Dec 20;13(12):e0209357. doi: 10.1371/journal.pone.0209357. eCollection 2018. Erratum in: PLoS One. 2019 Mar 5;14(3):e0213612.

5.

Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses.

Akhtar M, Chowdhury MI, Bhuiyan TR, Kaim J, Ahmed T, Rafique TA, Khan A, Rahman SIA, Khanam F, Begum YA, Sharif MZ, Islam LN, Carlin N, Maier N, Fix A, Wierzba TF, Walker RI, Bourgeois AL, Svennerholm AM, Qadri F, Lundgren A.

Vaccine. 2019 Sep 3;37(37):5645-5656. doi: 10.1016/j.vaccine.2018.11.040. Epub 2018 Nov 22.

6.

Defining endemic cholera at three levels of spatiotemporal resolution within Bangladesh.

Domman D, Chowdhury F, Khan AI, Dorman MJ, Mutreja A, Uddin MI, Paul A, Begum YA, Charles RC, Calderwood SB, Bhuiyan TR, Harris JB, LaRocque RC, Ryan ET, Qadri F, Thomson NR.

Nat Genet. 2018 Jul;50(7):951-955. doi: 10.1038/s41588-018-0150-8. Epub 2018 Jun 25.

7.

Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection.

Midani FS, Weil AA, Chowdhury F, Begum YA, Khan AI, Debela MD, Durand HK, Reese AT, Nimmagadda SN, Silverman JD, Ellis CN, Ryan ET, Calderwood SB, Harris JB, Qadri F, David LA, LaRocque RC.

J Infect Dis. 2018 Jul 13;218(4):645-653. doi: 10.1093/infdis/jiy192.

8.

Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial.

Qadri F, Ali M, Lynch J, Chowdhury F, Khan AI, Wierzba TF, Excler JL, Saha A, Islam MT, Begum YA, Bhuiyan TR, Khanam F, Chowdhury MI, Khan IA, Kabir A, Riaz BK, Akter A, Khan A, Asaduzzaman M, Kim DR, Siddik AU, Saha NC, Cravioto A, Singh AP, Clemens JD.

Lancet Infect Dis. 2018 Jun;18(6):666-674. doi: 10.1016/S1473-3099(18)30108-7. Epub 2018 Mar 14.

9.

In Situ Analyses Directly in Diarrheal Stool Reveal Large Variations in Bacterial Load and Active Toxin Expression of Enterotoxigenic Escherichiacoli and Vibrio cholerae.

Begum YA, Rydberg HA, Thorell K, Kwak YK, Sun L, Joffré E, Qadri F, Sjöling Å.

mSphere. 2018 Jan 24;3(1). pii: e00517-17. doi: 10.1128/mSphere.00517-17. eCollection 2018 Jan-Feb.

10.

Highly conserved type 1 pili promote enterotoxigenic E. coli pathogen-host interactions.

Sheikh A, Rashu R, Begum YA, Kuhlman FM, Ciorba MA, Hultgren SJ, Qadri F, Fleckenstein JM.

PLoS Negl Trop Dis. 2017 May 22;11(5):e0005586. doi: 10.1371/journal.pntd.0005586. eCollection 2017 May.

11.

Determinants of severe dehydration from diarrheal disease at hospital presentation: Evidence from 22 years of admissions in Bangladesh.

Andrews JR, Leung DT, Ahmed S, Malek MA, Ahmed D, Begum YA, Qadri F, Ahmed T, Faruque ASG, Nelson EJ.

PLoS Negl Trop Dis. 2017 Apr 27;11(4):e0005512. doi: 10.1371/journal.pntd.0005512. eCollection 2017 Apr.

12.

Resistance Pattern and Molecular Characterization of Enterotoxigenic Escherichia coli (ETEC) Strains Isolated in Bangladesh.

Begum YA, Talukder KA, Azmi IJ, Shahnaij M, Sheikh A, Sharmin S, Svennerholm AM, Qadri F.

PLoS One. 2016 Jul 18;11(7):e0157415. doi: 10.1371/journal.pone.0157415. eCollection 2016.

13.

Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh.

Qadri F, Wierzba TF, Ali M, Chowdhury F, Khan AI, Saha A, Khan IA, Asaduzzaman M, Akter A, Khan A, Begum YA, Bhuiyan TR, Khanam F, Chowdhury MI, Islam T, Chowdhury AI, Rahman A, Siddique SA, You YA, Kim DR, Siddik AU, Saha NC, Kabir A, Cravioto A, Desai SN, Singh AP, Clemens JD.

N Engl J Med. 2016 May 5;374(18):1723-32. doi: 10.1056/NEJMoa1510330.

14.

Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014.

Chowdhury F, Mather AE, Begum YA, Asaduzzaman M, Baby N, Sharmin S, Biswas R, Uddin MI, LaRocque RC, Harris JB, Calderwood SB, Ryan ET, Clemens JD, Thomson NR, Qadri F.

PLoS Negl Trop Dis. 2015 Nov 12;9(11):e0004183. doi: 10.1371/journal.pntd.0004183. eCollection 2015 Nov.

15.

Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.

Qadri F, Ali M, Chowdhury F, Khan AI, Saha A, Khan IA, Begum YA, Bhuiyan TR, Chowdhury MI, Uddin MJ, Khan JAM, Chowdhury AI, Rahman A, Siddique SA, Asaduzzaman M, Akter A, Khan A, Ae You Y, Siddik AU, Saha NC, Kabir A, Riaz BK, Biswas SK, Begum F, Unicomb L, Luby SP, Cravioto A, Clemens JD.

Lancet. 2015 Oct 3;386(10001):1362-1371. doi: 10.1016/S0140-6736(15)61140-0. Epub 2015 Jul 9.

PMID:
26164097
16.

Shift in phenotypic characteristics of enterotoxigenic Escherichia coli (ETEC) isolated from diarrheal patients in Bangladesh.

Begum YA, Baby NI, Faruque AS, Jahan N, Cravioto A, Svennerholm AM, Qadri F.

PLoS Negl Trop Dis. 2014 Jul 17;8(7):e3031. doi: 10.1371/journal.pntd.0003031. eCollection 2014 Jul.

17.

Antigen-specific memory B-cell responses to enterotoxigenic Escherichia coli infection in Bangladeshi adults.

Alam MM, Aktar A, Afrin S, Rahman MA, Aktar S, Uddin T, Rahman MA, Al Mahbuba D, Chowdhury F, Khan AI, Bhuiyan TR, Begum YA, Ryan ET, Calderwood SB, Svennerholm AM, Qadri F.

PLoS Negl Trop Dis. 2014 Apr 24;8(4):e2822. doi: 10.1371/journal.pntd.0002822. eCollection 2014 Apr.

18.

Geographical diversity in seasonality of major diarrhoeal pathogens in Bangladesh observed between 2010 and 2012.

Das SK, Begum D, Ahmed S, Ferdous F, Farzana FD, Chisti MJ, Latham JR, Talukder KA, Rahman MM, Begum YA, Faruque AS, Malek MA, Qadri F, Ahmed T, Alam N.

Epidemiol Infect. 2014 Dec;142(12):2530-41. doi: 10.1017/S095026881400017X. Epub 2014 Feb 13.

PMID:
24534384
19.

Etiological diversity of diarrhoeal disease in Bangladesh.

Das SK, Ahmed S, Ferdous F, Farzana FD, Chisti MJ, Latham JR, Talukder KA, Rahman M, Begum YA, Qadri F, Faruque AS, Ahmed T.

J Infect Dev Ctries. 2013 Dec 15;7(12):900-9. doi: 10.3855/jidc.3003.

20.

Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh.

Khan IA, Saha A, Chowdhury F, Khan AI, Uddin MJ, Begum YA, Riaz BK, Islam S, Ali M, Luby SP, Clemens JD, Cravioto A, Qadri F.

Vaccine. 2013 Dec 9;31(51):6058-64. doi: 10.1016/j.vaccine.2013.10.021. Epub 2013 Oct 22.

21.

Presence of enterotoxigenic Escherichia coli in biofilms formed in water containers in poor households coincides with epidemic seasons in Dhaka.

Ahmed D, Islam MS, Begum YA, Janzon A, Qadri F, Sjöling A.

J Appl Microbiol. 2013 Apr;114(4):1223-9. doi: 10.1111/jam.12109. Epub 2013 Jan 11.

22.

Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh.

Weil AA, Chowdhury F, Khan AI, Leung DT, Uddin T, Begum YA, Saha NC, Charles RC, Larocque RC, Harris JB, Ryan ET, Qadri F, Calderwood SB.

Am J Trop Med Hyg. 2012 Nov;87(5):921-6. doi: 10.4269/ajtmh.2012.12-0323. Epub 2012 Sep 10.

23.

Impact of rapid urbanization on the rates of infection by Vibrio cholerae O1 and enterotoxigenic Escherichia coli in Dhaka, Bangladesh.

Chowdhury F, Rahman MA, Begum YA, Khan AI, Faruque AS, Saha NC, Baby NI, Malek MA, Kumar AR, Svennerholm AM, Pietroni M, Cravioto A, Qadri F.

PLoS Negl Trop Dis. 2011 Apr 5;5(4):e999. doi: 10.1371/journal.pntd.0000999.

24.

Zinc influences innate immune responses in children with enterotoxigenic Escherichia coli-induced diarrhea.

Sheikh A, Shamsuzzaman S, Ahmad SM, Nasrin D, Nahar S, Alam MM, Al Tarique A, Begum YA, Qadri SS, Chowdhury MI, Saha A, Larson CP, Qadri F.

J Nutr. 2010 May;140(5):1049-56. doi: 10.3945/jn.109.111492. Epub 2010 Mar 17.

PMID:
20237063
25.

Concomitant enterotoxigenic Escherichia coli infection induces increased immune responses to Vibrio cholerae O1 antigens in patients with cholera in Bangladesh.

Chowdhury F, Begum YA, Alam MM, Khan AI, Ahmed T, Bhuiyan MS, Harris JB, LaRocque RC, Faruque AS, Endtz H, Ryan ET, Cravioto A, Svennerholm AM, Calderwood SB, Qadri F.

Infect Immun. 2010 May;78(5):2117-24. doi: 10.1128/IAI.01426-09. Epub 2010 Feb 22.

26.

Isolation of a bacteriophage specific for CS7-expressing strains of enterotoxigenic Escherichia coli.

Begum YA, Chakraborty S, Chowdhury A, Ghosh AN, Nair GB, Sack RB, Svennerholm AM, Qadri F.

J Med Microbiol. 2010 Mar;59(Pt 3):266-72. doi: 10.1099/jmm.0.014795-0. Epub 2009 Dec 10.

PMID:
20007763
27.

Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.

Shamsuzzaman S, Ahmed T, Mannoor K, Begum YA, Bardhan PK, Sack RB, Sack DA, Svennerholm AM, Holmgren J, Qadri F.

Vaccine. 2009 Feb 25;27(9):1386-92. doi: 10.1016/j.vaccine.2008.12.041. Epub 2009 Jan 13.

PMID:
19146897
28.

Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during floods in 1998, 2004, and 2007 in Dhaka, Bangladesh.

Harris AM, Chowdhury F, Begum YA, Khan AI, Faruque AS, Svennerholm AM, Harris JB, Ryan ET, Cravioto A, Calderwood SB, Qadri F.

Am J Trop Med Hyg. 2008 Nov;79(5):708-14.

29.

Complexity of rice-water stool from patients with Vibrio cholerae plays a role in the transmission of infectious diarrhea.

Nelson EJ, Chowdhury A, Harris JB, Begum YA, Chowdhury F, Khan AI, Larocque RC, Bishop AL, Ryan ET, Camilli A, Qadri F, Calderwood SB.

Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19091-6. Epub 2007 Nov 16.

30.

Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh.

Qadri F, Saha A, Ahmed T, Al Tarique A, Begum YA, Svennerholm AM.

Infect Immun. 2007 Aug;75(8):3961-8. Epub 2007 Jun 4.

31.

Comparison of enterotoxigenic Escherichia coli isolated from surface water and diarrhoeal stool samples in Bangladesh.

Begum YA, Talukder KA, Nair GB, Khan SI, Svennerholm AM, Sack RB, Qadri F.

Can J Microbiol. 2007 Jan;53(1):19-26.

PMID:
17496946
32.

Characterization of enterotoxigenic Escherichia coli from diarrhoeal patients in Bangladesh using phenotyping and genetic profiling.

Ansaruzzaman M, Bhuiyan NA, Begum YA, Kühn I, Nair GB, Sack DA, Svennerholm AM, Qadri F.

J Med Microbiol. 2007 Feb;56(Pt 2):217-22.

PMID:
17244803
33.

In vivo expression of the heat stable (estA) and heat labile (eltB) toxin genes of enterotoxigenic Escherichia coli (ETEC).

Sjöling A, Qadri F, Nicklasson M, Begum YA, Wiklund G, Svennerholm AM.

Microbes Infect. 2006 Oct;8(12-13):2797-802. Epub 2006 Sep 12.

PMID:
17045506
34.

Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants.

Qadri F, Chowdhury MI, Faruque SM, Salam MA, Ahmed T, Begum YA, Saha A, Al Tarique A, Seidlein LV, Park E, Killeen KP, Mekalanos JJ, Clemens JD, Sack DA; PXV Study Group.

Vaccine. 2007 Jan 4;25(2):231-8. Epub 2006 Sep 5.

PMID:
16996172
35.
36.

Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh.

Qadri F, Chowdhury MI, Faruque SM, Salam MA, Ahmed T, Begum YA, Saha A, Alam MS, Zaman K, Seidlein LV, Park E, Killeen KP, Mekalanos JJ, Clemens JD, Sack DA; Peru-15 Study Group.

J Infect Dis. 2005 Aug 15;192(4):573-9. Epub 2005 Jul 15.

PMID:
16028125
37.

Enterotoxigenic Escherichia coli and Vibrio cholerae diarrhea, Bangladesh, 2004.

Qadri F, Khan AI, Faruque AS, Begum YA, Chowdhury F, Nair GB, Salam MA, Sack DA, Svennerholm AM.

Emerg Infect Dis. 2005 Jul;11(7):1104-7.

38.

Enterotoxigenic Escherichia coli isolated from surface water in urban and rural areas of Bangladesh.

Begum YA, Talukder KA, Nair GB, Qadri F, Sack RB, Svennerholm AM.

J Clin Microbiol. 2005 Jul;43(7):3582-3. No abstract available.

39.

Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.

Saha D, LaRocque RC, Khan AI, Harris JB, Begum YA, Akramuzzaman SM, Faruque AS, Ryan ET, Qadri F, Calderwood SB.

J Infect Dis. 2004 Jun 15;189(12):2318-22. Epub 2004 May 25.

PMID:
15181581
40.

Human antibody response to longus type IV pilus and study of its prevalence among enterotoxigenic Escherichia coli in Bangladesh by using monoclonal antibodies.

Qadri F, Girón JA, Helander A, Begum YA, Asaduzzaman M, Xicohténcatl-Cortes J, Negrete E, Albert MJ.

J Infect Dis. 2000 Jun;181(6):2071-4. Epub 2000 May 16.

PMID:
10837196
41.

Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera.

Qadri F, Ahmed F, Karim MM, Wenneras C, Begum YA, Abdus Salam M, Albert MJ, McGhee JR.

Clin Diagn Lab Immunol. 1999 Nov;6(6):812-8.

42.

Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1.

Qadri F, Wennerås C, Albert MJ, Hossain J, Mannoor K, Begum YA, Mohi G, Salam MA, Sack RB, Svennerholm AM.

Infect Immun. 1997 Sep;65(9):3571-6.

43.

Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139.

Qadri F, Jonson G, Begum YA, Wennerås C, Albert MJ, Salam MA, Svennerholm AM.

Clin Diagn Lab Immunol. 1997 Jul;4(4):429-34.

44.

Evaluation of the monoclonal antibody-based kit Bengal SMART for rapid detection of Vibrio cholerae O139 synonym Bengal in stool samples.

Qadri F, Hasan JA, Hossain J, Chowdhury A, Begum YA, Azim T, Loomis L, Sack RB, Albert MJ.

J Clin Microbiol. 1995 Mar;33(3):732-4.

45.

The use of phage-sensitivity patterns for tracing heat labile toxin-positive (LT+) Escherichia coli.

Monsur KA, Clemens JD, Sack DA, Miah AL, Begum YA.

J Med Microbiol. 1989 Jan;28(1):43-7.

PMID:
2643704
46.

Evidence of multiple infections in cases of diarrhea due to enterotoxigenic Escherichia coli.

Monsur KA, Begum YA, Ahmed ZU, Rahman S.

J Infect Dis. 1989 Jan;159(1):144-5. No abstract available.

PMID:
2642521
47.

An evaluation of the pooling method for detecting enterotoxigenic Escherichia coli.

Monsur K, Kay BA, Miah AL, Begum YA.

J Diarrhoeal Dis Res. 1986 Dec;4(4):211-5. No abstract available.

PMID:
3312388
48.

Use of bacteriophage as a marker for identification of freshly-isolated individual Escherichia coli strains.

Monsur KA, Miah AL, Huq MI, Huq F, Poddar G, Salek MA, Begum YA.

J Diarrhoeal Dis Res. 1985 Sep;3(3):131-7. No abstract available.

PMID:
3914509

Supplemental Content

Loading ...
Support Center